$Fulgent Genetics (FLGT.US)$Revenue surged by 12 times in 20...

逍遥投资派 commented on a stock · Jul 16, 2023 23:03

$Fulgent Genetics (FLGT.US)$Revenue surged by 12 times in 2020, continued to grow by 1.4 times in 2021, typical pandemic stock. In 2022, there was a significant decline of 37.6%. Operating profit also reached a peak of 0.68 billion in 2021, then dropped sharply by 73% in 2022. Net income saw a substantial decrease of 72% in 2022.

Revenue declined by 79% in Q1 2023, both operating profit and net income entered into a loss range. Currently, the market cap is 1.15 billion, lacking investment value.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

See Original

Report

5194 Views

Comment

逍遥投资派

588

Followers

Following

3212

Visitors